Novaplex™ MG & MoxiR
Analytes
- Mycoplasma genitalium (MG)
- G248A (mutation of parC)
- A247C (mutation of parC)
- G248T (mutation of parC)
- G259A (mutation of parC)
- G259C (mutation of parC)
- G259T (mutation of parC)
Description
Targets 7
Sample Type
Urine
Genital swab
Liquid based cytology
Key Features
Novaplex™ MG & AziR Assay “Azithromycin resistance” and Novaplex™ MG & MoxiR Assay “Moxifloxacin”
- Simultaneous detection and identification of MG and mutations responsible for resistances of azithromycin (6 mutations) and moxifloxacin (6 mutations)
- Informative data with identification of each mutation related to drug resistances
- Short TAT (4 hours) from extraction to the final results
Novaplex™ NG &DR Assay
- Detects NG and drug resistance (Azithromycin, Ciprofloxacin) accurately with a single test to enable informative decision making
Azithromycin-resistance (A2059G, C2611T - Ciprofloxacin-resistance (S91F)
- Fast confirmation: Detects NG and drug resistance simultaneously with fast PCR TAT of 1.5 hours
- Combination test: Combination test available with Seegene’s STI assay (Novaplex CT/NG/MG/TV Assay) for informative STI testing
Compatible instrumentation
Automated Extraction & PCR Setup
Seegene NIMBUS
Seegene STARlet
Real-time PCR
CFX96™ Real-time PCR Detection System (Bio-Rad)
CFX96™ Dx System (Bio-Rad)
CFX96 Touch™ Real-Time PCR Detection System (Bio-Rad)
Seegene Viewer Software
Quick and easy data analysis and interpretation
Interface specialized for multiplex testing
Additional information
Volume | 124 rxns |
---|